Chisato Saeki

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Community Dwelling

Radiofrequency Ablation

Risk Assessment

Top Venues

Journal of clinical medicine

JGH open : an open access journal of gastroenterology and hepatology

Journal of gastroenterology and hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Chisato Saeki, Mitsuru Saito, Akihito Tsubota
Association of chronic liver disease with bone diseases and muscle weakness. Journal of bone and mineral metabolism (2024)
Chisato Saeki, Tomoya Kanai, Kaoru Ueda, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota
Prognostic significance of sarcopenia and severe vitamin D deficiency in patients with cirrhosis. JGH open : an open access journal of gastroenterology and hepatology 7 (5) (2023)
Chisato Saeki, Juntaro Matsuzaki, Masahiko Kuroda, Koji Fujita, Makiko Ichikawa, Satoko Takizawa, Keiko Takano, Tsunekazu Oikawa, Yasuni Nakanuma, Masayuki Saruta, Takahiro Ochiya, Akihito Tsubota
Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis. BMJ open gastroenterology 9 (1) (2022)
Chisato Saeki, Tsunekazu Oikawa, Kaoru Ueda, Masanori Nakano, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota
Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis. Diagnostics (Basel, Switzerland) 12 (8) (2022)
Masanori Nakano, Yuichi Torisu, Chika Nakagawa, Kaoru Ueda, Tomoya Kanai, Chisato Saeki, Tsunekazu Oikawa, Masayuki Saruta
Safety and efficacy of pentazocine-midazolam combination for pain and anxiety relief in radiofrequency ablation therapy for hepatocellular carcinoma. JGH open : an open access journal of gastroenterology and hepatology 6 (8) (2022)
Chisato Saeki, Tomoya Kanai, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota
Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis. JGH open : an open access journal of gastroenterology and hepatology 5 (7) (2021)
Chisato Saeki, Mitsuru Saito, Tomoya Kanai, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota
Clinical Usefulness of FRAX Score for Predicting Sarcopenia in Patients with Chronic Liver Disease. Journal of clinical medicine 10 (18) (2021)
Chisato Saeki, Akihito Tsubota
Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease. Life (Basel, Switzerland) 11 (9) (2021)
Chisato Saeki, Mitsuru Saito, Tomoya Kanai, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota
Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease. PloS one 16 (4) (2021)
Chisato Saeki, Tomoya Kanai, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota
Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease. Nutrients 12 (12) (2020)
Chisato Saeki, Tomoya Kanai, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota
Low Serum Branched-Chain Amino Acid and Insulin-Like Growth Factor-1 Levels Are Associated with Sarcopenia and Slow Gait Speed in Patients with Liver Cirrhosis. Journal of clinical medicine 9 (10) (2020)
Chisato Saeki, Tomoya Kanai, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masahiro Abo, Masayuki Saruta, Akihito Tsubota
Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease. Journal of clinical medicine 9 (8) (2020)
Chisato Saeki, Keiko Takano, Tsunekazu Oikawa, Yuma Aoki, Tomoya Kanai, Kazuki Takakura, Masanori Nakano, Yuichi Torisu, Nobuyuki Sasaki, Masahiro Abo, Tomokazu Matsuura, Akihito Tsubota, Masayuki Saruta
Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis. BMC musculoskeletal disorders 20 (1) (2019)
Keiko Takano, Chisato Saeki, Tsunekazu Oikawa, Akihisa Hidaka, Yusuke Mizuno, Jinya Ishida, Kazuki Takakura, Masanori Nakano, Yuichi Torisu, Katsushi Amano, Tomohisa Ishikawa, Mikio Zeniya, Akihito Tsubota, Masayuki Saruta
IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate. Journal of gastroenterology and hepatology 35 (4) (2019)